Liarozole: Difference between revisions

Content deleted Content added
moved to talk page
OAbot (talk | contribs)
m Open access bot: add pmc identifier to citation with #oabot.
Line 28:
}}
 
'''Liarozole''' is a [[retinoic acid]] metabolism-blocking drug and [[aromatase inhibitor]].<ref>{{cite journal|pmid=24102348|year=2013|last1=Vahlquist|first1=A|last2=Blockhuys|first2=S|last3=Steijlen|first3=P|last4=Van Rossem|first4=K|last5=Didona|first5=B|last6=Blanco|first6=D|last7=Traupe|first7=H|title=Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: Results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial|doi=10.1111/bjd.12626|journal=The British Journal of Dermatology|pages=173–81|volume=170|issue=1|pmc=4232915}}</ref>
 
==References==